Buthionine sulfoximine is a multitarget inhibitor of trypanothione synthesis in Trypanosoma cruzi

No abstract is available for this paper.

• Publication year

  2017

• Venue

  FEBS Letters

• Publication date

  2017-11-11

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/1873-3468.12904PMID 29127710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thiol redox biology of trypanosomatids and potential targets for chemotherapy.

  2016cited by this paper
• Chagas disease in Latin America: an epidemiological update based on 2010 estimates.

  2015cited by this paper
• Key proteins in the polyamine-trypanothione pathway as drug targets against Trypanosoma cruzi.

  2014cited by this paper
• Genetic Validation of Trypanosoma brucei Glutathione Synthetase as an Essential Enzyme

  2014cited by this paper
• Glutathione transporters.

  2013cited by this paper
• Glutathione Transport: A New Role for PfCRT in Chloroquine Resistance

  2013cited by this paper
• Identification of Protein Complex Associated with LYT1 of Trypanosoma cruzi

  2013cited by this paper
• Drug target validation of the trypanothione pathway enzymes through metabolic modelling

  2012cited by this paper
• The Human Serum Metabolome

  2011cited by this paper
• Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation

  2011cited by this paper
• Targeting trypanothione metabolism in trypanosomatid human parasites.

  2010cited by this paper
• Characterization of Trypanosoma cruzi L-cysteine transport mechanisms and their adaptive regulation.

  2009cited by this paper
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

  2009cited by this paper
• Metabolic Control Analysis: A Tool for Designing Strategies to Manipulate Metabolic Pathways

  2008cited by this paper
• Protein structure homology modeling using SWISS-MODEL workspace

  2008cited by this paper
• Leishmania Trypanothione Synthetase-Amidase Structure Reveals a Basis for Regulation of Conflicting Synthetic and Hydrolytic Activities

  2008cited by this paper
• Insights into the redox biology of Trypanosoma cruzi: Trypanothione metabolism and oxidant detoxification.

  2008cited by this paper
• A semiempirical free energy force field with charge‐based desolvation

  2007cited by this paper
• Protein production by auto-induction in high density shaking cultures.

  2005cited by this paper
• Buthionine Sulfoximine Increases the Toxicity of Nifurtimox and Benznidazole to Trypanosoma cruzi

  2005cited by this paper
• Glutathione metabolism and its implications for health.

  2004cited by this paper
• Effects of buthionine sulfoximine nifurtimox and benznidazole upon trypanothione and metallothionein proteins in Trypanosoma cruzi.

  2004cited by this paper
• The importance of glutathione in human disease.

  2003cited by this paper
• Gene Knockdown of γ-Glutamylcysteine Synthetase by RNAi in the Parasitic Protozoa Trypanosoma brucei Demonstrates That It Is an Essential Enzyme*

  2003cited by this paper
• Hgt1p, a High Affinity Glutathione Transporter from the Yeast Saccharomyces cerevisiae*

  2000cited by this paper
• Functional analysis of the intergenic regions of TcP2beta gene loci allowed the construction of an improved Trypanosoma cruzi expression vector.

  1999cited by this paper
• Biologic and pharmacologic regulation of mammalian glutathione synthesis.

  1999cited by this paper
• The enzymes of glutathione synthesis: gamma-glutamylcysteine synthetase.

  1999cited by this paper
• Biological characterization and genetic diversity of Mexican isolates of Trypanosoma cruzi.

  1998cited by this paper
• Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine, and 2-mercaptopropionylglycine in plasma and urine.

  1998cited by this paper
• Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi.

  1997cited by this paper
• Understanding the Control of Metabolism

  1996cited by this paper
• Glutathione and trypanothione in several strains of Trypanosoma cruzi: effect of drugs.

  1996cited by this paper
• Mitochondrial changes associated with glutathione deficiency.

  1995cited by this paper
• Analytical and preparative separation of the diastereomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis.

  1991cited by this paper
• Role of glutathione in the susceptibility of Trypanosoma cruzi to drugs.

  1989cited by this paper
• On the discovery of glutathione.

  1988cited by this paper
• Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis.

  1982cited by this paper
• Inhibition of glutathione synthesis as a chemotherapeutic strategy for trypanosomiasis

  1981cited by this paper
• Enzyme kinetics

  1975cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Knocking out histidine ammonia-lyase by using CRISPR-Cas9 abolishes histidine role in the bioenergetics and the life cycle of Trypanosoma cruzi

  2025cites this paper
• Targeting Trypanothione Synthetase and Trypanothione Reductase: Development of Common Inhibitors to Tackle Trypanosomatid Disease

  2025influential citation
• Repurposing the Antidiabetic Drugs Glyburide, Gliquidone, and Glipizide in Combination with Benznidazole for Trypanosoma cruzi Infection

  2024cites this paper
• Exploring Quinazoline Nitro-Derivatives as Potential Antichagasic Agents: Synthesis and In Vitro Evaluation

  2024cites this paper
• Targeting Trypanothione Metabolism in Trypanosomatids

  2024cites this paper
• Immunocompromisation of wheat host by L-BSO and 2,4-DPA induces susceptibility to the fungal pathogen Fusarium oxysporum

  2024cites this paper
• Repositioning FDA-Approved Drug Against Chagas Disease and Cutaneous Leishmaniosis by Structure-Based Virtual Screening.

  2024cites this paper
• Metabolic control analysis of the transsulfuration pathway and the compensatory role of the cysteine transport in Trypanosoma cruzi

  2023cites this paper
• Discovery of novel Leishmania major trypanothione synthetase inhibitors by high-throughput screening.

  2022cites this paper
• The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance

  2022cites this paper
• Identification of 1,2,3-triazolium salt-based inhibitors of Leishmania infantum trypanothione disulfide reductase with enhanced antileishmanial potency in cellulo and increased selectivity.

  2022cites this paper
• A Spatiotemporal Characterisation of Redox Molecules in Planarians, with a Focus on the Role of Glutathione during Regeneration

  2021cites this paper
• Computational approaches for drug discovery against trypanosomatid-caused diseases

  2020cites this paper
• Metabolic Control Analysis for Drug Target Prioritization in Trypanosomatids.

  2020cites this paper
• Hits and Lead Discovery in the Identification of New Drugs against the Trypanosomatidic Infections

  2019cites this paper
• Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity

  2019influential citation
• The thiol-polyamine metabolism of Trypanosoma cruzi: molecular targets and drug repurposing strategies.

  2018cites this paper
• Drug Target Selection for Trypanosoma cruzi Metabolism by Metabolic Control Analysis and Kinetic Modeling.

  2018cites this paper